Sofinnova News
Sofinnova Crossover & Sofinnova Industrial Biotech
Sofinnova Partners’ Antoine Papiernik spoke with In Vivo magazine’s William Looney on European #venturecapital, #investment strategy, and more. https://bit.ly/2GIP9rZ @INVIVOnow @BillInVivo
Sofinnova Partners’ Antoine Papiernik spoke with In Vivo magazine’s William Looney on European #venturecapital, #investment strategy, and more. https://bit.ly/2GIP9rZ @INVIVOnow @BillInVivo
Related Strategy
CrossoverRelated Deal lead
Antoine Papiernik
Related News
Neurent Medical secures €25 million growth debt facility from Claret Capital Partners to accelerate commercial expansion
Mainstay Medical announces two-year outcomes from RESTORE clinical trial of ReActiv8®
Sensorion announces approval of clinical trial application in France for SENS-601 gene therapy for GJB2-related hearing loss
Biotalys secures product registration in California for EVOCA®, strengthening regulatory pathway for lead asset
Inventiva announces last patient visit in NATiV3 Phase 3 clinical trial of Lanifibranor in MASH